Search
05/01/2025
Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research Society
Flores-Aguilar, L, Hamlett, ED, Araya, P, Barone, E, Bhattacharyya, A, Carmona-Iragui, M, Chan, L, Christian, B, Costa, ACS, Costanzo, F, Soriano, LD, Dierssen, M, Eichler, EE, Fisher, E, Galbraith, M, Ghosh, S, Gimenez, S, Guedj, F, Guidi, S, Iulita, MF, Mobley, W, Pelleri, MC, Potier, MC, Rabin, KR, Rachubinski, A, Rebillat, AS, Rubenstein, E, Saternos, H, Sordo, L, Strydom, A, Valle-Tamayo, N, Waugh, KA, Yu, E, Zeldich, E, Busciglio, J, Head, E. Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research Society. NEUROMOLECULAR MEDICINE. 2025; 27(1)DOI:10.1007/s12017-024-08824-y. PMID:39756004. IF:3.900(Q2/3D).
01/01/2025
The Discovery of Autoimmune Nodopathies and the Impact of IgG4 Antibodies in Autoimmune Neurology
Querol, L, Dalakas, MC. The Discovery of Autoimmune Nodopathies and the Impact of IgG4 Antibodies in Autoimmune Neurology. Neurology-Neuroimmunology & Neuroinflammation. 2025; 12(1)DOI:10.1212/NXI.0000000000200365. PMID:39671536. IF:7.500(Q1/1D).
01/01/2025
Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravis
Reyes-Leiva, D, Carbayo, A, Vesperinas-Castro, A, Rojas-Garcia, R, Querol, L, Turon-Sans, J, Pla-Junca, F, Olivé, M, Gallardo, E, Pujades-Rodriguez, M, Cortés-Vicente, E. Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravis. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32(1)DOI:10.1111/ene.16463. PMID:39624955. IF:3.900(Q1/3D).
01/01/2025
Practitioner's perception of myasthenia gravis management recommendations in clinical practice: a cross-sectional survey study
Cortes-Vicente, E, Guerrero-Sola, A, Caballero-Martinez, F, Campos-Lucas, FJ, Gómez-Salgado, J, Monge-Martin, D, Alvarez-Velasco, R. Practitioner's perception of myasthenia gravis management recommendations in clinical practice: a cross-sectional survey study. Therapeutic Advances in Chronic Disease. 2025; 16DOI:10.1177/20406223251368063. PMID:40949050. IF:2.800(Q2/5D).
01/01/2025
Approaches for treating neuropsychiatric symptoms in Parkinson's disease: a narrative review
Rodríguez-Antigüedad, J, Olmedo-Saura, G, Pagonabarraga, J, Martínez-Horta, S, Kulisevsky, J. Approaches for treating neuropsychiatric symptoms in Parkinson's disease: a narrative review. Therapeutic Advances in Neurological Disorders. 2025; 18DOI:10.1177/17562864251336903. PMID:40433403. IF:4.100(Q1/2D).
01/01/2025
Linking cognitive function and biological markers in depression: Can IL-6 plasma levels and attention domain be used as an ensemble classification system?
Portella, MJ, Arteaga-Henríquez, G, de Diego-Adeliño, J, Trujols, J, Puigdemont, D, Pérez, J, Alemany, C, Carrasco-Hernández, J, Udina, M, Cardoner, N, Vicent-Gil, M. Linking cognitive function and biological markers in depression: Can IL-6 plasma levels and attention domain be used as an ensemble classification system?. GENERAL HOSPITAL PSYCHIATRY. 2025; 92DOI:10.1016/j.genhosppsych.2024.10.003. PMID:39395857. IF:3.700(Q1/3D).